Lannett Co (LCI) PT Lowered to 'Street Low' $5 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to Lannett Co (LCI) PT Lowered to 'Street Low' $5 at Deutsche Bank
August 20, 2018 2:19 PM EDT
Raymond James analyst Elliot Wilbur downgraded Lannett Co (NYSE: LCI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Lannett Co click here. For more ratings news on Lannett Co click here.
Shares of Lannett Co closed at $13.50 yesterday.
...
More
August 20, 2018 12:57 PM EDT
Craig-Hallum analyst Matthew Hewitt downgraded Lannett Co (NYSE: LCI) from Buy to Neutral with a price target of $7.00.
The analyst said the end of the JSP relationship creates a noticeable cash flow void.
For an analyst ratings summary and ratings... More
August 20, 2018 10:03 AM EDT
Roth Capital analyst Scott Henry downgraded Lannett Co (NYSE: LCI) from Buy to Neutral with a price target of $8.00 (from $23.00).
For an analyst ratings summary and ratings history on Lannett Co click here. For more ratings news on Lannett Co click here.
Shares of Lannett Co closed at $13.50 yesterday.
...
More
August 20, 2018 9:17 AM EDT
Today's Pre-Open Movers
Seven Stars Cloud Group, Inc. (NASDAQ: SSC) 109% HIGHER; announced a ground-breaking, three-year, exclusive $24B deal with National Transportation Capacity Co Ltd (NTS) to issue fixed income lease financing-based products, through a global strategic alliance network which operates in a regulatory compliant manner, for large-scale electric bus upgrades, as part of the Chinese government's regulations for all buses to be replaced with electric buses by 2021 (within the next three years). The market size for the mandatory replacements and upgrades to achieve fully-electric bus operations in... More
August 20, 2018 6:58 AM EDT
Lannett Company, Inc. (NYSE: LCI) today said that its distribution agreement with Jerome Stevens Pharmaceuticals (JSP), which expires on March 23, 2019, will not be renewed.
"The Steinlauf family advised us this past Friday evening that they will not renew our agreement to distribute three JSP products: Butalbital, Aspirin, Caffeine with Codeine Phosphate Capsules USP, Digoxin Tablets USP and Levothyroxine Sodium Tablets USP, upon its expiration in March 2019," said Tim Crew, chief executive officer of Lannett. "The family has assured us of a continuous supply of the products through March of next year. These... More
